Sign In
Buy CLXT
$6.30
+0 (+0%)
At Close: Aug 30, 2023
Calyxt to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021 at 4:30 p.m. Eastern Time
04:30pm, Monday, 19'th Jul 2021
ROSEVILLE, Minn., July 19, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT) will hold a conference call on Thursday, August 5, 2021 at 4:30 p.m.
Calyxt Appoints Michael A. Carr As CEO
06:17am, Friday, 16'th Jul 2021
Biotechnology company Calyxt Inc (NASDAQ: CLXT) has appointed Michael A. Carr as President and Chief Executive Officer, effective July 27, 2021.
Calyxt Announces Expansion of Hemp Breeding Platform with Seedless Hemp Innovation
08:31am, Thursday, 08'th Jul 2021
Triploid Breeding Process is Calyxt's Second Announced Advancement and Part of a Comprehensive Approach to Improving Hemp Genetics ROSEVILLE, MN / ACCESSWIRE / July 8, 2021 / Calyxt, Inc. (NASDAQ:CLXT
The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the Century
07:30am, Thursday, 01'st Jul 2021
Doudna's breakthrough in CRISPR has since ushered in a new era of genetic engineering, making these the best gene-editing stocks to buy. The post The Top 7 Gene-Editing Stocks to Buy for the Biggest S
Calyxt: Proprietary TALEN Plant-Technology Offers Multi-Industry Growth
01:15pm, Wednesday, 23'rd Jun 2021
Calyxt is a plant-technology company that develops plant-based innovations and solutions aiming to disrupt a broad group of industries. Calyxt is a leading gene-editor with exclusive access to the par
Calyxt, Inc. (CLXT) Q1 2021 Results - Earnings Call Transcript
09:46am, Sunday, 09'th May 2021
Calyxt, Inc. (CLXT) Q1 2021 Results - Earnings Call Transcript
Calyxt Announces Next Generation Premium Soybean Product Line Performance Best-In-Class for High Oleic, Ultra-Low Linolenic Profile
08:31am, Tuesday, 04'th May 2021
Next Generation Premium Soybean Product Line Contains Ultra-Low Levels of Linolenic Acid Positioning it to be the Most Stable Premium Soybean Oil Available on the Market R&D Advancement with Complex P
Calyxt Successfully Transforms Hemp Genome
08:31am, Thursday, 29'th Apr 2021
New Hemp Transformation Technology Unlocks Capabilities to Selectively Breed and Deliver Improvements in Hemp Traits for Key Markets Including Protein, Fiber, Advanced Materials and Wellness Patent-Pe
Calyxt to Present at Upcoming Investor and Industry Conferences
08:31am, Tuesday, 20'th Apr 2021
ROSEVILLE, MN / ACCESSWIRE / April 20, 2021 / Calyxt, Inc . (NASDAQ:CLXT), a plant-based technology company, will participate in the following investor and industry conferences during the month of May
Calyxt to Host First Quarter 2021 Financial Results Conference Call on Thursday, May 6, 2021 at 4:30 p.m. Eastern Time
08:31am, Thursday, 15'th Apr 2021
Calyxt to Host First Quarter 2021 Financial Results Conference Call on Thursday, Ma y 6 , 202 1 at 4 :30 p .m. Eastern Time ROSEVILLE, MN / ACCESSWIRE / April 15, 2021 / Calyxt, Inc. (NASDAQ:CLXT), a
Calyxt Using A More Conventional Model To Pursue Significant New Agri-Bio Market Opportunities
09:30pm, Wednesday, 24'th Mar 2021
Calyxt has changed its operating strategy to a more conventional agri-bio seed/trait model similar to those pursued by established agri-bio names like Bayer and Corteva. Calyxt is targeting new high-r
Calyxt, Inc. (CLXT) Q4 2020 Results - Earnings Call Transcript
07:48pm, Thursday, 04'th Mar 2021
Calyxt, Inc. (CLXT) Q4 2020 Results - Earnings Call Transcript
Calyxt (CLXT) Reports Q4 Loss, Tops Revenue Estimates
07:43pm, Thursday, 04'th Mar 2021
Calyxt (CLXT) delivered earnings and revenue surprises of -32.00% and 77.18%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Calyxt Q4 Earnings
05:21pm, Thursday, 04'th Mar 2021
-Shares of Calyxt (NASDAQ:CLXT) were flat after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 10.81% year over year to ($0.33), which missed the
Calyxt Reports Fourth Quarter and Full Year 2020 Financial Results
04:01pm, Thursday, 04'th Mar 2021
Continued to Progress Development of Winter Oats and Hemp, Both Targeted at Large Addressable Markets Secured Commitment from ADM to Purchase Remaining 2019 Grain Inventory and All 2020 Grain Producti
